Yoshihito Matsumoto Selected Research

Yoshihito Matsumoto Research Topics

Disease

10	Neoplasms (Cancer) 02/2007 - 01/2003
4	Pituitary Neoplasms (Pituitary Adenoma) 08/2006 - 01/2004
3	Meningioma (Meningiomas) 02/2007 - 12/2003
2	Glioma (Gliomas) 02/2005 - 08/2004
2	Lymphoma (Lymphomas) 08/2004 - 01/2004
1	Seizures (Absence Seizure) 01/2010
1	Epilepsy (Aura) 01/2010
1	Drug Resistant Epilepsy 01/2010
1	Adenoma (Adenomas) 08/2006
1	Prolactinoma (Prolactinomas) 08/2006
1	Neurologic Manifestations (Neurological Manifestations) 05/2006
1	Alzheimer Disease (Alzheimer's Disease) 02/2006
1	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2006
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 12/2005
1	Meningocele 06/2005
1	Breast Neoplasms (Breast Cancer) 02/2005
1	Hemianopsia (Bitemporal Hemianopsia) 08/2004
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2004
1	Craniopharyngioma (Craniopharyngiomas) 01/2004
1	Hemorrhage 01/2004
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2004
1	Germinoma 01/2004
1	Brain Edema (Cerebral Edema) 07/2003
1	Cold Injury 07/2003

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 02/2007 - 12/2003
4	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2005 - 01/2003
3	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2007 - 01/2004
3	multidrug resistance-associated protein 1IBA 02/2007 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 09/2005 - 08/2004
3	Matrix Metalloproteinases (MMPs)IBA 08/2005 - 01/2003
3	Pharmaceutical PreparationsIBA 02/2005 - 01/2004
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2007 - 01/2004
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2006 - 12/2003
2	Etoposide (VP 16)FDA LinkGeneric 02/2005 - 08/2004
1	gamma-Aminobutyric Acid (GABA)IBA 01/2010
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2007
1	Adrenocorticotropic Hormone (ACTH)FDA Link 08/2006
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2005
1	Heparin (Liquaemin)FDA LinkGeneric 12/2005
1	Actins (F Actin)IBA 08/2005
1	Topoisomerase II InhibitorsIBA 02/2005
1	Amsacrine (AMSA)IBA 02/2005
1	Glucose (Dextrose)FDA LinkGeneric 08/2004
1	Phosphorothioate OligonucleotidesIBA 08/2004
1	Therapeutic UsesIBA 08/2004
1	Antisense OligonucleotidesIBA 08/2004
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2004
1	Methotrexate (Mexate)FDA LinkGeneric 01/2004
1	Carboplatin (JM8)FDA LinkGeneric 01/2004
1	MIB-1 antibodyIBA 12/2003
1	RNA (Ribonucleic Acid)IBA 12/2003
1	Hematoxylin (Haematoxylon)IBA 07/2003
1	A 7 (A-7)IBA 07/2003
1	Evans Blue (Blue, Evans)FDA Link 07/2003
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2003
1	Matrix Metalloproteinase InhibitorsIBA 07/2003
1	CGS 27023AIBA 07/2003
1	CopperIBA 07/2003
1	NitrogenIBA 07/2003

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 02/2007 - 01/2004
3	Therapeutics 01/2010 - 01/2004
3	Transplantation 01/2010 - 02/2006
3	Adjuvant Chemotherapy 02/2007 - 01/2004
2	Decompression 05/2006 - 01/2004
1	Catheters 12/2005
1	Mechanical Thrombolysis 12/2005
1	Thrombolytic Therapy 12/2005
1	Perforator Flap 06/2005
1	Craniotomy 01/2004